跳至主要内容
临床试验/JPRN-UMIN000013120
JPRN-UMIN000013120已完成未知

Efficacy of steroid therapy for primary prevention of cerebral amyloid angiopathy-related hemorrhage. - Efficacy of steroid therapy for primary prevention of cerebral amyloid angiopathy-related hemorrhage.

Aizawa Hospital0 个研究点目标入组 10 人开始时间: 2014年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
41years-old 至 86years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have met these exclusion criteria should be excluded. Age is younger than 41 years old or older than 86 years old when informed consent was obtained. Patients who have uncontrolled hypertension (systolic blood pressure>=160mmHg or diastolic blood pressure>=100mmHg), taken antithrombotic medication (antiplatelet or anticoagulant drug), abnormal glucose tolerance (HbA1c>=6.5%(NGSP)). Patients who may have difficulty in adherence to continuous and regular medication.

研究者

相似试验